The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Molecular mechanisms and clinical applications of angiogenesis
Open accessAbstract
Blood vessels deliver oxygen and nutrients to every part of the body, but also nourish diseases such as cancer. Over the past decade, our understanding of the molecular mechanisms of angiogenesis (blood vessel growth) has increased at an explosive rate and has led to the approval of anti-angiogenic drugs for cancer and eye diseases. So far, hundreds of thousands of patients have benefited from blockers of the angiogenic protein vascular endothelial growth factor, but limited efficacy and resistance remain outstanding problems. Recent preclinical and clinical studies have shown new molecular targets and principles, which may provide avenues for improving the therapeutic benefit from anti-angiogenic strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“In clinical settings, this approach has been proven to be ineffective when used alone [23].”
From Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis (2023) · cites this paper as [23]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition to increasing drug resistance, a high SS could influence tumor cells' gene expression, comprise immune cells ability to kill cancerous cells or even turn macrophages to tumorfriendly cells, thereby enhancing the metastatic potential of cancer cells [180-184].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [184]
Experimental — accuracy not yet measuredIn the citing paper
“This disparity is, in part, attributed to VEGF-independent nonangiogenic mechanisms of vascularization (such as vessel co-option) that are exploited by cancer cells at the early stages of metastasis formation6,9,55,56”
From Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges (2018) · cites this paper as [9]
In the citing paper
“Several cellular and molecular mechanisms of escape from antiangiogenic therapies have been postulated and investigated, including activation of alternative angiogenic pathways, recruitment of proangiogenic myeloid cells, increased pericyte cell coverage of tumour blood vessels, increased tumour cell invasion, and alternative modes of vessel recruitment7,9,80”
From Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges (2018) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527 · cited 1×
“Tumour vessels become abnormal in almost all aspects of their structure and functio”
BackgroundSelf-citationAngiogenesis in health and disease
Carmeliet, P. (2003) · Nature Medicine · doi:10.1038/nm0603-653 · Cited by 4,379
Self-citationIntegrins in cancer: biological implications and therapeutic opportunities
Desgrosellier, J. S., & Cheresh, D. A. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2748 · Cited by 3,815
Microenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684
Angiogenesis in life, disease and medicine
Carmeliet, P. (2005) · Nature · doi:10.1038/nature04478 · Cited by 3,551
Self-citationVEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., et al. (2005) · Nature · doi:10.1038/nature04186 · Cited by 3,288
Modes of resistance to anti-angiogenic therapy
Bergers, G., & Hanahan, D. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2442 · Cited by 2,953 · cited 1×
“Aberrant FGF signalling promotes tumour angiogenesis and mediates the escape of tumour vascularization from VEGF- or epidermal growth factor receptor (EGFR)-inhibitor treatmen”
BackgroundMatrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., et al. (2000) · Nature Cell Biology · doi:10.1038/35036374 · Cited by 2,797
Molecular regulation of vessel maturation
Jain, R. K. (2003) · Nature Medicine · doi:10.1038/nm0603-685 · Cited by 2,594
Self-citationHypoxia-inducible factors and the response to hypoxic stress
Majmundar, A. J., Wong, W. J., & Simon, M. C. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.022 · Cited by 2,380
Flagged first, then by citations
Cited by
Sorted by citations
Items 601–700 of 1,021
Polymer Hydrogels to Guide Organotypic and Organoid Cultures
Magno, V., Meinhardt, A., & Werner, C. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202000097 · Cited by 110
Small GTPase R-Ras Regulates Integrity and Functionality of Tumor Blood Vessels
Sawada, J., Urakami, T., Li, F., Urakami, A., Zhu, W., Fukuda, M., Li, D. Y., Ruoslahti, E. I., & Komatsu, M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.06.013 · Cited by 110
Plaque angiogenesis and its relation to inflammation and atherosclerotic plaque destabilization
de Vries, M. R., & Quax, P. H. A. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000339 · Cited by 110
What Is the Role of Imaging at Primary Diagnostic Work-Up in Uterine Cervical Cancer?
Haldorsen, I. S., Lura, N. G., Blaakær, J., Fischerová, D., & Werner, H. M. J. (2019) · Current Oncology Reports · doi:10.1007/s11912-019-0824-0 · Cited by 109
Anti-angiogenic properties of carnosol and carnosic acid, two major dietary compounds from rosemary
López-Jiménez, A., García‐Caballero, M., Medina, M. Á., & Quesada, A. R. (2011) · European Journal of Nutrition · doi:10.1007/s00394-011-0289-x · Cited by 109
miR-1 and miR-206 regulate angiogenesis by modulating VegfA expression in zebrafish
Stahlhut, C. E., Suárez, Y., Lü, J., Mishima, Y., & Giráldez, A. J. (2012) · Development · doi:10.1242/dev.083774 · Cited by 109
Saraswati, S., Kanaujia, P. K., Kumar, S., Kumar, R., & Alhaider, A. A. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-82 · Cited by 109
Albrecht-Schgoer, K., Schgoer, W., Holfeld, J., Theurl, M., Wiedemann, D., Steger, C. M., Gupta, R., Semsroth, S., Fischer‐Colbrie, R., Beer, A., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.076950 · Cited by 108
Clinical Pilot Application of Super-Resolution US Imaging in Breast Cancer
Dencks, S., Piepenbrock, M., Opacic, T., Krauspe, B., Stickeler, E., Kiessling, F. M., & Schmitz, G. (2018) · IEEE Transactions on Ultrasonics Ferroelectrics and Frequency Control · doi:10.1109/tuffc.2018.2872067 · Cited by 108
Acute Myeloid Leukemia and the Bone Marrow Niche—Take a Closer Look
Behrmann, L., Wellbrock, J., & Fiedler, W. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00444 · Cited by 108
The kallikrein-related peptidase family: Dysregulation and functions during cancer progression
Kryza, T., Silva, L. M., Loessner, D., Heuzé‐Vourc'h, N., & Clements, J. A. (2015) · Biochimie · doi:10.1016/j.biochi.2015.09.002 · Cited by 108
The Role of Mast Cell Specific Chymases and Tryptases in Tumor Angiogenesis
de Souza, D. A., Santana, A. C., da Silva, E. Z. M., Oliver, C., & Jamur, M. C. (2015) · BioMed Research International · doi:10.1155/2015/142359 · Cited by 108
Schmidt, W. U., Endres, M., Dimeo, F., & Jungehulsing, G. J. (2013) · Cerebrovascular Diseases · doi:10.1159/000347061 · Cited by 108
Vascularization of tissue-engineered skeletal muscle constructs
Gholobova, D., Terrie, L., Gérard, M., Declercq, H., & Thorrez, L. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119708 · Cited by 107
New diagnostic and therapeutic strategies for myocardial infarction via nanomaterials
Shi, H., Huang, Z., Xu, T., Sun, A., & Ge, J. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.103968 · Cited by 107
Ceresoli, G. L., Zucali, P. A., Mencoboni, M., Botta, M., Grossi, F., Cortinovis, D. L., Zilembo, N., Ripa, C., Tiseo, M., Favaretto, A. G., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.368 · Cited by 106
An Overview of Vasculogenic Mimicry in Breast Cancer
Andonegui-Elguera, M. A., Alfaro‐Mora, Y., Cáceres-Gutiérrez, R. E., Caro-Sánchez, C. H. S., Herrera, L. A., & Díaz‐Chávez, J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00220 · Cited by 106
Deng, Y., Zhou, Z., Ji, W., Lin, S., & Wang, M. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01814-4 · Cited by 106
Eyeing central neurons in vascular growth and reparative angiogenesis
Sapieha, P. S. (2012) · Blood · doi:10.1182/blood-2012-04-396846 · Cited by 106
Targeting the Microenvironment in Advanced Colorectal Cancer
Tauriello, D. V. F., & Batlle, E. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.08.001 · Cited by 106
Zheng, Y., Zhou, R., Cai, J., Yang, N., Wen, Z., Zhang, Z., Sun, H., Huang, G., Guan, Y., Huang, N., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-23-0025 · Cited by 105
Genetic lineage tracing identifies endocardial origin of liver vasculature
Zhang, H., Pu, W., Tian, X., Huang, X., He, L., Liu, Q., Li, Y., Zhang, L., He, L., Liu, K., et al. (2016) · Nature Genetics · doi:10.1038/ng.3536 · Cited by 105
Thymidine Phosphorylase in Cancer; Enemy or Friend?
Elamin, Y. Y., Rafee, S., Osman, N., O'Byrne, K. J., & Gately, K. A. (2015) · Cancer Microenvironment · doi:10.1007/s12307-015-0173-y · Cited by 105
MicroRNA-107 contributes to post-stroke angiogenesis by targeting Dicer-1
Li, Y., Mao, L., Gao, Y., Baral, S., Zhou, Y., & Hu, B. (2015) · Scientific Reports · doi:10.1038/srep13316 · Cited by 105
Huang, D., Huang, M., Lin, X., & Huang, Q. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s141476 · Cited by 105
ALK1 Loss Results in Vascular Hyperplasia in Mice and Humans Through PI3K Activation
Alsina‐Sanchís, E., García-Ibáñez, Y., Figueiredo, A. M., Riera‐Domingo, C., Figueras, A., Matías‐Guiu, X., Casanovas, O., Botella, L. M., Pujana, M. Á., Riera-Mestre, A., et al. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.310760 · Cited by 105
lncRNA NR2F1‐AS1 promotes breast cancer angiogenesis through activating IGF‐1/IGF‐1R/ERK pathway
Zhang, Q., Li, T., Wang, Z., Kuang, X., Shao, N., & Lin, Y. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15499 · Cited by 105
Anastomosis of endothelial sprouts forms new vessels in a tissue analogue of angiogenesis
Song, J. W., Bazou, D., & Munn, L. L. (2012) · Integrative Biology · doi:10.1039/c2ib20061a · Cited by 105
Cao, Z., Shang, B., Zhang, G., Miele, L., Sarkar, F. H., Wang, Z. P., & Zhou, Q. (2013) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2013.08.001 · Cited by 105
Endothelial cell-derived GABA signaling modulates neuronal migration and postnatal behavior
Li, S., Pandit, P. K. T., Joshee, S., Kirschstein, T., Subburaju, S., Khalili, J. S., Kloepper, J., Du, C., Elkhal, A., Szabó, G., et al. (2017) · Cell Research · doi:10.1038/cr.2017.135 · Cited by 104
Self-citationArachidonic Acid Metabolite as a Novel Therapeutic Target in Breast Cancer Metastasis
Borin, T. F., Angara, K., Rashid, M. H., Achyut, B. R., & Arbab, A. S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122661 · Cited by 104
Voutouri, C., Kirkpatrick, N. D., Chung, E., Mpekris, F., Baish, J. W., Munn, L. L., Fukumura, D., Stylianopoulos, T., & Jain, R. K. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1818322116 · Cited by 104
Self-citationByun, J. S., & Gardner, K. L. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.01.009 · Cited by 104
Central Role of Metabolism in Endothelial Cell Function and Vascular Disease
Bierhansl, L., Conradi, L., Treps, L., Dewerchin, M. A., & Carmeliet, P. (2017) · Physiology · doi:10.1152/physiol.00031.2016 · Cited by 107
Self-citationXia, H., Chen, J., Shi, M., Gao, H., Sekar, K., Seshachalam, V. P., Ooi, L. L., & Hui, K. M. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.05.005 · Cited by 103
Winnik, S. H., Lohmann, C., Siciliani, G., von Lukowicz, T., Kuschnerus, K., Kränkel, N., Brokopp, C. E., Enseleit, F., Michels, S., Ruschitzka, F. T., et al. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.03.010 · Cited by 103
Stromal Versican Regulates Tumor Growth by Promoting Angiogenesis
Asano, K., Nelson, C. M., Nandadasa, S., Aramaki‐Hattori, N., Lindner, D. J., Alban, T. J., Inagaki, J., Ohtsuki, T., Oohashi, T., Apte, S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-17613-6 · Cited by 103
Liu, Y., Zhou, J., Li, Q., Li, L., Jia, Y., Geng, F., Zhou, J., & Yin, T. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.02.019 · Cited by 103
Mapping the cardiac vascular niche in heart failure
Peisker, F., Halder, M., Nagai, J. S., Ziegler, S. M., Kaesler, N., Hoeft, K., Li, R., Bindels, E. M., Kuppe, C., Moellmann, J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30682-0 · Cited by 103
Tubulin Colchicine Binding Site Inhibitors as Vascular Disrupting Agents in Clinical Developments
Ji, Y.-T., Liu, Y.-N., & Liu, Z. (2015) · Current Medicinal Chemistry · doi:10.2174/0929867322666150114163732 · Cited by 102
Multiple biological functions and pharmacological effects of lycorine
Cao, Z., Yang, P., & Zhou, Q. (2013) · Science China Chemistry · doi:10.1007/s11426-013-4967-9 · Cited by 102
Endothelial cells promote triple‐negative breast cancer cell metastasis via PAI‐1 and CCL5 signaling
Zhang, W., Xu, J., Fang, H., Tang, L., Chen, W., Sun, Q., Zhang, Q., Yang, F., Sun, Z., Cao, L., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201700237rr · Cited by 102
Liu, P., Atkinson, S. J., Akbareian, S. E., Zhou, Z., Münsterberg, A., Robinson, S. D., & Bao, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-12855-w · Cited by 102
Carrier-free nano-integrated strategy for synergetic cancer anti-angiogenic therapy and phototherapy
Wei, Z., Liang, P., Xie, J., Song, C., Tang, C., Wang, Y., Yin, X., Cai, Y., Han, W., & Dong, X. (2019) · Chemical Science · doi:10.1039/c8sc04123g · Cited by 102
Tumor vessel co-option probed by single-cell analysis
Teuwen, L.-A. M. N., de Rooij, L. P. M. H., Cuypers, A., Rohlenová, K., Dumas, S. J., García‐Caballero, M., Meta, E., Amersfoort, J., Taverna, F., Becker, L. M., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109253 · Cited by 102
Self-citationOrgan-on-a-chip systems for vascular biology
Mandrycky, C., Howard, C. C., Rayner, S. G., Shin, Y. J., & Zheng, Y. Y. (2021) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2021.06.002 · Cited by 102
Dennis, S. C., Berkland, C. J., Bonewald, L. F., & Detamore, M. S. (2014) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2014.0419 · Cited by 102
The Ubiquitin-Proteasome System Meets Angiogenesis
Rahimi, N. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0555 · Cited by 102
Emerging translational approaches to target STAT3 signalling and its impact on vascular disease
Dutzmann, J., Daniel, J., Bauersachs, J. K., Hilfiker‐Kleiner, D., & Sedding, D. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv103 · Cited by 104
Forkhead box transcription factor FoxC1 preserves corneal transparency by regulating vascular growth
Seo, S., Singh, H. P., Lacal, P. M., Sasman, A., Fatima, A., Liu, T., Schultz, K. M., Losordo, D. W., Lehmann, O. J., & Kume, T. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109540109 · Cited by 102
Awada, H. K., Hwang, M. P., & Wang, Y. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.12.025 · Cited by 102
Cerebral Neovascularization in Diabetes: Implications for Stroke Recovery and beyond
Ergul, A., Abdelsaid, M. A., Fouda, A. Y., & Fagan, S. C. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.18 · Cited by 101
Chen, X.-H., Ren, K., Liang, P., Chai, Y., Chen, K.-S., & Gao, J. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i9.1666 · Cited by 101
Insights into the regulatory role of circRNA in angiogenesis and clinical implications
Liu, Y., Yang, Y., Wang, Z., Fu, X., Chu, X., Li, Y., Wang, Q., He, X., Li, M., Wang, K., et al. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.02.017 · Cited by 102
Chavali, M., Ulloa-Navas, M. J., Pérez-Borredá, P., García‐Verdugo, J. M., McQuillen, P. S., Huang, E. J., & Rowitch, D. H. (2020) · Neuron · doi:10.1016/j.neuron.2020.09.033 · Cited by 101
Rahmani, A. H., Babiker, A. Y., & Anwar, S. (2023) · Molecules · doi:10.3390/molecules28135152 · Cited by 101
Hydrogels for therapeutic cardiovascular angiogenesis
Rufaihah, A. J., & Seliktar, D. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.07.003 · Cited by 101
Vascular tissue engineering: biodegradable scaffold platforms to promote angiogenesis
Serbo, J. V., & Gerecht, S. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt156 · Cited by 101
Dual signaling evoked by oxidized LDLs in vascular cells
Nègre‐Salvayre, A., Augè, N., Camaré, C., Bacchetti, T., Ferretti, G., & Salvayre, R. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.02.006 · Cited by 101
The vascular biology of macrophage migration inhibitory factor (MIF)
Asare, Y., Schmitt, M. M. N., & Bernhagen, J. (2013) · Thrombosis and Haemostasis · doi:10.1160/th12-11-0831 · Cited by 100
van Meeteren, L. A., Thorikay, M., Bergqvist, S., Pardali, E., Stampino, C. G., Hu‐Lowe, D. D., Goumans, M., & ten Dijke, P. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.338103 · Cited by 100
The Wilms’ tumour suppressor Wt1 is a major regulator of tumour angiogenesis and progression
Wagner, K., Cherfils‐Vicini, J., Hosen, N., Hohenstein, P., Gilson, É., Hastie, N. D., Michiels, J., & Wagner, N. (2014) · Nature Communications · doi:10.1038/ncomms6852 · Cited by 100
The regulation of cancer cell migration by lung cancer cell-derived exosomes through TGF-β and IL-10
Wang, Y., YI, J., Chen, X., Zhang, Y., Xu, M. Q., & Yang, Z. (2015) · Oncology Letters · doi:10.3892/ol.2015.4044 · Cited by 100
Anti-tumor and anti-metastatic roles of cordycepin, one bioactive compound of Cordyceps militaris
Jin, Y. H., Meng, X. W., Qiu, Z., Su, Y., Yu, P., & Qu, P. (2018) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2018.05.016 · Cited by 100
Ash, D., Varadarajan, S., Youn, S., Okur, M. N., Das, A., O’Bryan, J. P., McMenamin, M., Hou, Y., Kaplan, J. H., Fukai, T., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23408-1 · Cited by 100
Dragneva, G., Korpisalo, P., & Ylä‐Herttuala, S. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.010413 · Cited by 100
VEGF in Tumor Progression and Targeted Therapy
Chekhonin, V. P., Shein, S. A., Korchagina, A. A., & Gurina, O. I. (2013) · Current Cancer Drug Targets · doi:10.2174/15680096113139990074 · Cited by 99
In vitro pre-vascularisation of tissue-engineered constructs A co-culture perspective
Baldwin, J., Antille, M., Bonda, U., De‐Juan‐Pardo, E. M., Khosrotehrani, K., Ivanovski, S., Petcu, E. B., & Hutmacher, D. W. (2014) · Vascular Cell · doi:10.1186/2045-824x-6-13 · Cited by 99
Natural products against cancer angiogenesis
Bairi, K. E., El-Kenawy, A. E.-M., Rahman, H. S., Guaâdaoui, A., & Najda, A. (2016) · Tumor Biology · doi:10.1007/s13277-016-5364-8 · Cited by 99
Whole Brain Radiation-Induced Vascular Cognitive Impairment: Mechanisms and Implications
Warrington, J. P., Ashpole, N. M., Csiszár, A., Lee, Y. W., Ungvari, Z. I., & Sonntag, W. E. (2013) · Journal of Vascular Research · doi:10.1159/000354227 · Cited by 99
Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis
Subhan, M. A., Parveen, F., Filipczak, N., Yalamarty, S. S. K., & Torchilin, V. P. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13030389 · Cited by 98
“In clinical settings, this approach has been proven to be ineffective when used alone [23].”
MethodAnti-angiogenesis in cancer therapy: Hercules and hydra
Bellou, S., Pentheroudakis, G. E., Murphy, C., & Fotsis, T. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.05.015 · Cited by 98
Ma, J., Qin, C., Wu, J., Zhang, H., Zhuang, H., Zhang, M., Zhang, Z., Ma, L., Wang, X., Ma, B., et al. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202100523 · Cited by 98
Restoring the renal microvasculature to treat chronic kidney disease
Long, D. A., Norman, J. T., & Fine, L. G. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.219 · Cited by 98
Heme accumulation in endothelial cells impairs angiogenesis by triggering paraptosis
Petrillo, S., Chiabrando, D., Genova, T., Fiorito, V., Ingoglia, G., Vinchi, F., Mussano, F. D., Carossa, S., Silengo, L., Altruda, F., et al. (2017) · Cell Death and Differentiation · doi:10.1038/s41418-017-0001-7 · Cited by 98
Bubb, K. J., Aubdool, A. A., Moyes, A. J., Lewis, S., Drayton, J. P., Tang, O., Mehta, V., Zachary, I. C., Abraham, D., Tsui, J. C. S., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.036344 · Cited by 98
Extracellular vesicles as new players in angiogenesis
Kholia, S., Ranghino, A., Garnieri, P., Lopatina, T., Deregibus, M. C., Rispoli, P., Brizzi, M. F., & Camussi, G. (2016) · Vascular Pharmacology · doi:10.1016/j.vph.2016.03.005 · Cited by 97
TRPV4 channels regulate tumor angiogenesis via modulation of Rho/Rho kinase pathway
Thoppil, R. J., Cappelli, H. C., Adapala, R. K., Kanugula, A. K., Paruchuri, S. M., & Thodeti, C. K. (2016) · Oncotarget · doi:10.18632/oncotarget.8405 · Cited by 97
MicroRNA-29c functions as a tumor suppressor by targeting VEGFA in lung adenocarcinoma
Liu, L., Bi, N., Wu, L., Ding, X., Men, Y., Zhou, W., Li, L., Zhang, W., Shi, S., Song, Y., et al. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0620-0 · Cited by 97
Stem cell secretome as a new booster for regenerative medicine
Xia, J., Minamino, S., Kuwabara, K., & Arai, S. (2019) · BioScience Trends · doi:10.5582/bst.2019.01226 · Cited by 97
The Role of Neurovascular System in Neurodegenerative Diseases
Ahmad, A., Patel, V., Xiao, J., & Khan, M. M. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02023-z · Cited by 97
Du, Y., Wang, Y., Bao, Q., Xu, X., Xu, C., Wang, S., Liu, Q., Liu, F., Zeng, Y., Wang, Y., et al. (2024) · Advanced Materials · doi:10.1002/adma.202412815 · Cited by 97
Ultrasound-mediated drug delivery for cardiovascular disease
Sutton, J. T., Haworth, K. J., Pyne‐Geithman, G. J., & Holland, C. K. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.772578 · Cited by 97
Role of the tumor stroma in resistance to anti-angiogenic therapy
Huijbers, E. J. M., B, J. R. V. B., Thijssen, V. L., Sabrkhany, S., Nowak-Sliwinska, P. M., & Griffioen, A. W. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.02.002 · Cited by 97
Masotti, A., Miller, M. R., Celluzzi, A., Rose, L., Micciulla, F., Hadoke, P. W. F., Stefano Bellucci, A., & Caporali, A. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.02.017 · Cited by 97
Emdad, L., Das, S. K., Dasgupta, S., Hu, B., Sarkar, D., & Fisher, P. B. (2013) · Advances in cancer research · doi:10.1016/b978-0-12-401676-7.00003-6 · Cited by 96
The Drug Developments of Hydrogen Sulfide on Cardiovascular Disease
Wen, Y.-D., Wang, H., & Zhu, Y. Z. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/4010395 · Cited by 96
Anticancer bioactivity of compounds from medicinal plants used in European medieval traditions
Teiten, M.-H., Gaascht, F., Dicato, M. A., & Diederich, M. F. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.08.007 · Cited by 96
Li, W., Zong, S., Shi, Q., Li, H., Xu, J., & Hou, F. (2016) · Scientific Reports · doi:10.1038/srep37534 · Cited by 96
Missiaen, R., Mazzone, M., & Bergers, G. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.06.002 · Cited by 96
Visuri, M. T., Honkonen, K. M., Hartiala, P., Tervala, T. V., Halonen, P. J., Junkkari, H., Knuutinen, N., Ylä‐Herttuala, S., Alitalo, K. K., & Saarikko, A. M. (2015) · Angiogenesis · doi:10.1007/s10456-015-9469-2 · Cited by 96
Xiao, X., Guo, P., Chen, Z., El‐Gohary, Y., Wiersch, J. C., Gaffar, I. M., Prasadan, K. L., Shiota, C., & Gittes, G. K. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.422949 · Cited by 95
Luo, L., Zhang, X., Hirano, Y., Tyagi, P., Barabás, P., Uehara, H., Miya, T. R., Singh, N., Archer, B. J., Qazi, Y., et al. (2013) · ACS Nano · doi:10.1021/nn305958y · Cited by 95
Interstitial Fibrosis Restricts Osmotic Water Transport in Encapsulating Peritoneal Sclerosis
Morelle, J., Sow, A., Hautem, N., Bouzin, C., Crott, R., Devuyst, O., & Goffin, E. J. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014090939 · Cited by 95
Nanomaterials for Angiogenesis in Skin Tissue Engineering
Cui, L., Liang, J., Liu, H., Zhang, K., & Li, J. (2020) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2019.0337 · Cited by 95
Plaque neovascularization: defense mechanisms, betrayal, or a war in progress
Moreno, P., Purushothaman, M., & Purushothaman, K. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06497.x · Cited by 95
Paramashivam, S. K., Elayaperumal, K., Natarajan, B. B., Ramamoorthy, M. D., Balasubramanian, S., & Dhiraviam, K. N. (2015) · Bioinformation · doi:10.6026/97320630011073 · Cited by 95
Aflibercept—a Decoy VEGF Receptor
Ciombor, K. K., & Berlin, J. D. (2014) · Current Oncology Reports · doi:10.1007/s11912-013-0368-7 · Cited by 95
TGF-β Mediates Homing of Bone Marrow–Derived Human Mesenchymal Stem Cells to Glioma Stem Cells
Shinojima, N., Hossain, A., Takezaki, T., Fueyo-Margareto, J., Gumin, J., Gao, F., Nwajei, F., Marini, F. C., Andreeff, M., Kuratsu, J., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3086 · Cited by 95
Florijn, B. W., Bijkerk, R., van der Veer, E. P., & van Zonneveld, A. J. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx223 · Cited by 95
Metadata
- Authors
- Carmeliet, P., & Jain, R. K.
- Affiliations
- Harvard University (US)
- Corresponding author
- Carmeliet, Peter
- Jain, Rakesh K.
- ORCID
- Carmeliet, Peter
- Venue
- Nature
- Published
- 2011-05
- Volume
- 473
- Issue
- 7347
- Pages
- 298-307
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4049445
- OpenAlex
- W1992112921
- Semantic Scholar
- cc1723f25e863386b91340ea03cd76a22de359ae
- Cited by
- 5,467
- References
- 100
- Citations by year
- 2026: 238 · 2025: 316 · 2024: 308 · 2023: 364 · 2022: 393 · 2021: 442 · 2020: 399 · 2019: 399 · 2018: 384 · 2017: 454 · 2016: 369 · 2015: 375 · 2014: 326 · 2013: 342 · 2012: 284
- FWCI
- 29.09
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Cancer Institute (R01CA115767, R01CA085140, P01CA080124, R01CA126642, R01CA163815)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Health Sciences › Medicine › Oncology › Vascular Tumors and Angiosarcomas
- Keywords
- angiogenesis, angiogenesis inhibitors, vascular endothelial growth factor, VEGF inhibitors, drug resistance, molecular targets, cancer, eye diseases, blood vessel development
- MeSH terms
- Animals, Blood Vessels, Fibroblast Growth Factors, Humans, Platelet-Derived Growth Factor, Transforming Growth Factor beta, Neovascularization, Physiologic, Angiogenesis Inhibitors, Vesicular Transport Proteins, Vascular Endothelial Growth Factor A
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
